Efficacy and safety of pregabalin 600 mg/d for treating painful diabetic peripheral neuropathy: A double-blind placebo-controlled trial

BACKGROUND: Recent consensus guidelines recommend pregabalin as a first-tier treatment for painful diabetic peripheral neuropathy (DPN). We evaluated the efficacy of pregabalin 600 mg/d (300 mg dosed BID) versus placebo for relieving DPN-associated neuropathic pain, and assessed its safety using obj...

Descripción completa

Detalles Bibliográficos
Autores principales: Arezzo, Joseph C, Rosenstock, Julio, LaMoreaux, Linda, Pauer, Lynne
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565674/
https://www.ncbi.nlm.nih.gov/pubmed/18796160
http://dx.doi.org/10.1186/1471-2377-8-33

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565674/
https://www.ncbi.nlm.nih.gov/pubmed/18796160
http://dx.doi.org/10.1186/1471-2377-8-33

Ejemplares similares